Pre-eclampsia and Cardiovascular Disease Risk Assessment in Women

Abstract

The underlying contributors of many cardiovascular events are often present decades before the onset of clinical symptoms, and the presence of risk factors in early life significantly influences risk of premature cardiovascular disease (CVD). The considerable burden of CVD in women and on health care resources necessitates an emphasis on prevention and early risk screening in women, before the development of the disease itself. The 2011 update to the American Heart Association's Effectiveness-Based Guidelines for the prevention of CVD acknowledges the contribution of the common pregnancy-related medical complications to a woman's cardiovascular risk, identifying pre-eclampsia (PE), gestational hypertension, and gestational diabetes mellitus as risk factors for heart disease and stroke. The aims of this review are to examine risk factors in young women and their role in the development of premature CVD, with particular attention paid to PE as a marker of a woman's cardiovascular risk. Current screening practices will be discussed, as will their influences on identifying and reducing cardiovascular risk and subsequent disease in younger women.

Keywords

cardiovascular disease - women - pregnancy - pre-eclampsia

Note

The article was completed by M.S.Q.M. and edited by G.N.S.

• References

• 1 Mosca L, Benjamin EJ, Berra K , et al; American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011; 57 (12) 1404-1423
• 2 Long T, Taubenheim A, Wayman J, Temple S, Ruoff B. “The Heart Truth:” Using the Power of Branding and Social Marketing to Increase Awareness of Heart Disease in Women. Soc Mar Q 2008; 14 (3) 3-29
• 3 Lee DS, Chiu M, Manuel DG , et al; Canadian Cardiovascular Outcomes Research Team. Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors. CMAJ 2009; 181 (3–4) E55-E66
• 4 Spaan J, Peeters L, Spaanderman M, Brown M. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension 2012; 60 (6) 1368-1373
• 5 Heidenreich PA, Trogdon JG, Khavjou OA , et al; American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123 (8) 933-944
• 6 Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E ; Writing Group. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation 1997; 96 (7) 2468-2482
• 7 Mosca L, Grundy SM, Judelson D , et al. Guide to Preventive Cardiology for Women. AHA/ACC Scientific Statement Consensus panel statement. Circulation 1999; 99 (18) 2480-2484
• 8 Canto JG, Shlipak MG, Rogers WJ , et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000; 283 (24) 3223-3229
• 9 McSweeney JC, Cody M, O'Sullivan P, Elberson K, Moser DK, Garvin BJ. Women's early warning symptoms of acute myocardial infarction. Circulation 2003; 108 (21) 2619-2623
• 10 Giralt D, Domingues-Montanari S, Mendioroz M , et al. The gender gap in stroke: a meta-analysis. Acta Neurol Scand 2012; 125 (2) 83-90
• 11 Ryan CJ, DeVon HA, Zerwic JJ. Typical and atypical symptoms: diagnosing acute coronary syndromes accurately. Am J Nurs 2005; 105 (2) 34-36
• 12 Chandra NC, Ziegelstein RC, Rogers WJ , et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998; 158 (9) 981-988
• 13 McLaughlin TJ, Soumerai SB, Willison DJ , et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996; 156 (7) 799-805
• 14 Yusuf S, Hawken S, Ounpuu S , et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364 (9438) 937-952
• 15 Unger T, Chung O, Csikos T , et al. Angiotensin receptors. J Hypertens Suppl 1996; 14 (5) S95-S103
• 16 Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282 (21) 2035-2042
• 17 Stokes III J, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study—30 years of follow-up. Hypertension 1989; 13 (5, Suppl): I13-I18
• 18 Vasan RS, Larson MG, Leip EP , et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345 (18) 1291-1297
• 19 Lewington S, Clarke R, Qizilbash N, Peto R, Collins R ; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360 (9349) 1903-1913
• 20 Wilkins K, Campbell NR, Joffres MR , et al. Blood pressure in Canadian adults. Health Rep 2010; 21 (1) 37-46
• 21 Oda E, Abe M, Kato K, Watanabe K, Veeraveedu PT, Aizawa Y. Gender differences in correlations among cardiovascular risk factors. Gend Med 2006; 3 (3) 196-205
• 22 Shields M, Carroll MD, Ogden CL. Adult obesity prevalence in Canada and the United States. NCHS Data Brief 2011; (56) 1-8
• 23 Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67 (5) 968-977
• 24 Kannel WB, Cupples LA, Ramaswami R, Stokes III J, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 1991; 44 (2) 183-190
• 25 Li TY, Rana JS, Manson JE , et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006; 113 (4) 499-506
• 26 Després JP, Lemieux I, Bergeron J , et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28 (6) 1039-1049
• 27 Després J-P. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J Suppl 2006; 8 (Supplement B): B4-B12
• 28 Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282 (16) 1523-1529
• 29 Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162 (16) 1867-1872
• 30 Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163 (4) 427-436
• 31 Legato MJ. Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy. Am J Cardiol 2000; 86 (12A) 15L-18L
• 32 Kolovou GD, Anagnostopoulou KK, Damaskos DS , et al. Gender differences in the lipid profile of dyslipidemic subjects. Eur J Intern Med 2009; 20 (2) 145-151
• 33 Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol 1992; 2 (1–2) 161-176
• 34 Walsh JM, Grady D. Treatment of hyperlipidemia in women. JAMA 1995; 274 (14) 1152-1158
• 35 Mosca L, Banka CL, Benjamin EJ , et al; Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women's Association; Centers for Disease Control and Prevention; Office of Research on Women's Health; Association of Black Cardiologists; American College of Physicians; World Heart Federation; National Heart, Lung, and Blood Institute; American College of Nurse Practitioners. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007; 115 (11) 1481-1501
• 36 LaRosa JC. Triglycerides and coronary risk in women and the elderly. Arch Intern Med 1997; 157 (9) 961-968
• 37 Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112 (2) 432-437
• 38 Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2 (2) 120-126
• 39 Levit RD, Reynolds HR, Hochman JS. Cardiovascular disease in young women: a population at risk. Cardiol Rev 2011; 19 (2) 60-65
• 40 Giugliano D, Marfella R, Coppola L , et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997; 95 (7) 1783-1790
• 41 Kawano H, Motoyama T, Hirashima O , et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34 (1) 146-154
• 42 Bowie A, Owens D, Collins P, Johnson A, Tomkin GH. Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?. Atherosclerosis 1993; 102 (1) 63-67
• 43 Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 1993; 36 (11) 1119-1125
• 44 Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000; 342 (13) 905-912
• 45 Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30 Suppl A : S32-S37
• 46 Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998; 21 (8) 1258-1265
• 47 Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 1983; 118 (4) 489-496
• 48 Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23 (2) 105-111
• 49 Goldberg RJ, Larson M, Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. Arch Intern Med 1996; 156 (5) 505-509
• 50 Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998; 158 (6) 617-621
• 51 Tanasescu M, Cho E, Manson JE, Hu FB. Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr 2004; 79 (6) 999-1005
• 52 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106 (25) 3143-3421
• 53 Grundy SM, Cleeman JI, Daniels SR , et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112 (17) 2735-2752
• 54 Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Rep 2009; (13) 1-7
• 55 Riediger ND, Clara I. Prevalence of metabolic syndrome in the Canadian adult population. CMAJ 2011; 183 (15) E1127-E1134
• 56 Dunn NR, Faragher B, Thorogood M , et al. Risk of myocardial infarction in young female smokers. Heart 1999; 82 (5) 581-583
• 57 Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003; 290 (1) 86-97
• 58 Krauss RM, Eckel RH, Howard B , et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000; 102 (18) 2284-2299
• 59 Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000; 343 (1) 16-22
• 60 U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office
• 61 Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 2007; 116 (19) 2110-2118
• 62 Hu FB, Stampfer MJ, Colditz GA , et al. Physical activity and risk of stroke in women. JAMA 2000; 283 (22) 2961-2967
• 63 US Department of Health and Human Services. Physical Activity Guidelines Advisory Committee final report. http://www.health.gov/PAGuidelines/Report/Default.aspx
• 64 Lloyd-Jones DM, Nam BH, D'Agostino Sr RB , et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004; 291 (18) 2204-2211
• 65 Murabito JM, Pencina MJ, Nam BH , et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 2005; 294 (24) 3117-3123
• 66 Reilly JJ, Armstrong J, Dorosty AR , et al; Avon Longitudinal Study of Parents and Children Study Team. Early life risk factors for obesity in childhood: cohort study. BMJ 2005; 330 (7504) 1357
• 67 Gilman SE, Rende R, Boergers J , et al. Parental smoking and adolescent smoking initiation: an intergenerational perspective on tobacco control. Pediatrics 2009; 123 (2) e274-e281
• 68 Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003; 15 (6) 465-471
• 69 Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177-191
• 70 Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994; 101 (8) 669-674
• 71 Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002; 325 (7356) 157-160
• 72 Mostello D, Catlin TK, Roman L, Holcomb Jr WL, Leet T. Preeclampsia in the parous woman: who is at risk?. Am J Obstet Gynecol 2002; 187 (2) 425-429
• 73 Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335 (7627) 974
• 74 Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents?. Circulation 2010; 122 (6) 579-584
• 75 Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 2013; 28 (1) 1-19
• 76 Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323 (7323) 1213-1217
• 77 Kestenbaum B, Seliger SL, Easterling TR , et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis 2003; 42 (5) 982-989
• 78 Wikström AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005; 112 (11) 1486-1491
• 79 Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155 (5) 1011-1016
• 80 Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357 (9273) 2002-2006
• 81 Stepan H, Nordmeyer AK, Faber R. Proteinuria in hypertensive pregnancy diseases is associated with a longer persistence of hypertension postpartum. J Hum Hypertens 2006; 20 (2) 125-128
• 82 Suzuki H, Watanabe Y, Arima H, Kobayashi K, Ohno Y, Kanno Y. Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol 2008; 12 (2) 102-109
• 83 Berks D, Steegers EA, Molas M, Visser W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 2009; 114 (6) 1307-1314
• 84 McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156 (5) 918-930
• 85 Smith GN, Walker MC, Liu A , et al; Pre-Eclampsia New Emerging Team (PE-NET). A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200 (1) 58.e1-58.e8
• 86 Smith GN, Pudwell J, Walker M, Wen SW. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can 2012; 34 (9) 830-835
• 87 Smith GN, Pudwell J, Walker M, Wen SW. Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can 2012; 34 (9) 836-841
• 88 Manten GT, Sikkema MJ, Voorbij HA, Visser GH, Bruinse HW, Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 2007; 26 (1) 39-50
• 89 van Rijn BB, Nijdam ME, Bruinse HW , et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol 2013; 121 (5) 1040-1048
• 90 Wolf M, Hubel CA, Lam C , et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004; 89 (12) 6239-6243
• 91 Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366 (9499) 1797-1803
• 92 Mosca L, Benjamin EJ, Berra K , et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the american heart association. Circulation 2011; 123 (11) 1243-1262
• 93 Hoedjes M, Berks D, Vogel I , et al. Motivators and barriers to a healthy postpartum lifestyle in women at increased cardiovascular and metabolic risk: a focus-group study. Hypertens Pregnancy 2012; 31 (1) 147-155
• 94 Brown MC, Bell R, Collins C , et al. Women's perception of future risk following pregnancies complicated by preeclampsia. Hypertens Pregnancy 2013; 32 (1) 60-73
• 95 Hoedjes M, Berks D, Vogel I , et al. Preferences for postpartum lifestyle counseling among women sharing an increased cardiovascular and metabolic risk: a focus group study. Hypertens Pregnancy 2011; 30 (1) 83-92
• 96 Mosca L, Mochari H, Christian A , et al. National study of women's awareness, preventive action, and barriers to cardiovascular health. Circulation 2006; 113 (4) 525-534
• 97 Smith GN, Pudwell J, Roddy M. The Maternal Health Clinic: a new window of opportunity for early heart disease risk screening and intervention for women with pregnancy complications. J Obstet Gynaecol Can 2013; 35 (9) 831-839
• 98 Cusimano MC, Pudwell J, Roddy M , et al. The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications. Am J Obstet Gynecol 2014; 210 (5) 438.e1-438.e9